Drug facts
MoleculeAlbuterol (Ventolin HFA)
Generics already compete: 23 makers on the market. 37 A-rated products from 23 makers substitute at the counter.
Proventil was first approved by the FDA on 05/07/1982 under NDA 017853; the application holder is Schering Corp Sub Schering Plough Corp. The Orange Book lists NDA 017853 as discontinued.
The latest NADAC for ALBUTEROL SULFATE 2 MG TAB is $0.31 per unit (as of 10/28/2026).
Holder Schering Corp Sub Schering Plough CorpApplication NDA 017853Approved 05/07/1982
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Proventil patent listed in the Orange Book Orange Book
02Competition
- Generics
- 23 generic makers Orange Book
- First generic approved
- 12/05/1989 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Albuterol profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.31 per unitALBUTEROL SULFATE 2 MG TAB, as of 10/28/2026 CMS NADAC
- Latest recall
- 03/17/2026Class II, Albuterol Sulfate Inhalation Solution, Nephron Sc, LLC FDA enforcement
04Product
- Application holder
- Schering Corp Sub Schering Plough Corp Orange Book
- Application
- NDA 017853 Orange Book
- First approved
- 05/07/1982 Orange Book
- Dosage forms
- aerosol, metered; powder, metered; solution; syrup; tablet
- Routes
- inhalation, oral
- Other brand names
- Proair HFAProair RespiclickProventil-HFA
- Status
- NDA 017853 discontinued Orange Book
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.